Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jan;27(1):15-23.
doi: 10.1002/hup.1265. Epub 2012 Jan 9.

Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implications

Matthieu P K Crews  1 , Oliver D Howes
Affiliations
Review

Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implications

Matthieu P K Crews et al. Hum Psychopharmacol. 2012 Jan.

Abstract

Objective: Osteoporosis is increasingly common worldwide and there is a growing concern that the long-term use of antipsychotic medications increases the risk of this disorder. In this review, we consider whether antipsychotics may contribute to the development of osteoporosis through reductions in bone mineral density, discuss the possible mechanisms involved and consider the clinical implications of such a relationship.

Methods: We searched the literature for studies in this area published between 1966 and 2010 using the Medline and PubMed databases, supplemented by hand searches of retrieved reports.

Results: The available data indicate that statistically significant reductions in bone mineral density are frequently seen in patients prescribed with antipsychotic medications and suggest that there is a higher incidence of clinically significant reductions compared with the normal population.

Conclusions: Clinicians should be aware for the potential negative effects of antipsychotic medications on bone mineral density, particularly in patients with additional risk factors for osteoporosis. Recommendations regarding routine monitoring of bone mineral density for patients prescribed antipsychotic medications cannot be made on the basis of existing evidence, and more research is required.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram (selection strategy) of included studies
Figure 1
Figure 1
Flow diagram (selection strategy) of included studies
See this image and copyright information in PMC

References

    1. Akande B, Wieck A, Haddad PM. Bone mineral density in premenopausal women with antipsychotic-induced hyperprolactinaemia. Eur Neuropsychopharmacol. 2002;12:311–312. - PubMed
    1. Becker D, Liver O, Mester R, Micha R, Weizman A, Weiss M. Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients. J Clin Psychiatry. 2003;64(7):761–766. - PubMed
    1. Bonjour JP, Rizzoli R. Bone acquisition in adolescence. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. Academic Press; San Diego, CA: 1996. pp. 465–476.
    1. Burge RT. The cost of osteoporotic fractures in the UK: Projections for 2000-2020. J Med Econ. 2001;4:51–62.
    1. Carey JJ, Delaney MF, Love TE, Cromer BA, Miller PD, Richmond BJ, Manilla-McIntosh M, Lewis SA, Thomas CL, Licata AA. Dual-energy X-ray absorptiometry diagnostic discordance between Z-scores and T-scores in young adults. J Clin Densitom. 2009;12(1):11–16. - PubMed

Substances